Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Abbvie Limited .
Filed returns
31
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Abbvie Limited | Economic Development and Industry | Competitiveness of Europe and Ireland in relation to Life sciences (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | Abbvie Limited | Environment | Urban Waste water treatment Directive (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Abbvie Limited | Health | Dermatology waiting lists (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2022 | Abbvie Limited | Health | The need to speed up access to innovative medicines in Ireland, particularly in areas with high unmet need (Legislation) | 9 | On lobbying.ie |
| Sep–Dec 2021 | Abbvie Limited | Health | Access to medicines in Ireland (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2021 | Abbvie Limited | Health | CSR activities - (corporate social responsibilities) (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2021 | Abbvie Limited | Health | Access and reimbursement to medicines (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2020 | Abbvie Limited | Health | Health Policy engagements (Public policy or programme) | 11 | On lobbying.ie |
| May–Aug 2020 | Abbvie Limited | Health | World Hepatitis Day 2020 (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2020 | Abbvie Limited | Health | Discussion about access to medicines (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2019 | Abbvie Limited | Health | Invitation to attend AbbVie presentation (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Abbvie Limited | Health | Presentation during IBEC regional meeting (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2019 | Abbvie Limited | Health | To invite representatives to attend AbbVie STEM events (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2019 | Abbvie Limited | Health | Discussion on Budget 2019 (Matters involving public funds) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Abbvie Limited | Health | Briefing note on access to medicines (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2019 | Abbvie Limited | Health | Meetings to discuss access to medicines (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2019 | Abbvie Limited | Health | Parkinsons Disease funding in Ireland and medicines reimbursement (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2019 | Abbvie Limited | Health | To discuss access to medicines and pharmacy-led substitution (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2019 | Abbvie Limited | Health | To invite representatives to attend AbbVie corporate responsibility event (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2019 | Abbvie Limited | Health | To discuss HCV elimination (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2019 | Abbvie Limited | Health | To discuss access to oncology medicines, HCV elimination and non-medical switching (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2019 | Abbvie Limited | Health | To discuss access to oncology medicines, HCV elimination and non-medical switching (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2019 | Abbvie Limited | Health | To discuss Ireland's HCV elimination policy (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2018 | Abbvie Limited | Health | To highlight delays in access to an innovative new medicine for Chronic Lymphocytic Leukaemia for patients in Ireland that is available in other European countries (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2018 | Abbvie Limited | Health | To highlight the delays in patients getting access to new innovative medicines and ask for a national policy on access to medicines that will improve Ireland's ranking relative to other European countries (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2017 | Abbvie Limited | Health | To brief TD's on how Ireland is falling behind other countries in Europe on speed of access to new medicines (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2017 | Abbvie Limited | Health | To update on the operation of the IPHA agreement and policy on access to medicines and deliver our position on Biosimilar Policy. To brief on the work Abbvie are doing in promoting the uptake of STEM subjects (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2017 | Abbvie Limited | Health | To update on the operations of the IPHA agreement and policy on access to new medicine and deliver our position on the new Biosimilar Policy (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2017 | Abbvie Limited | Health | To discuss the operation of the IPHA agreement and policy on access to new innovative medicines (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2016 | Abbvie Limited | Health | To discuss the Fianna Fail Private Members Bill to amend the Health (Pricing and Supply of Medical Goods) Bill 2015 (Legislation) | 1 | On lobbying.ie |
| May–Aug 2016 | Abbvie Limited | Health | To communicate the value to the State of securing a successor supply agreement with the Irish Pharmaceutical Healthcare Association (IPHA) (Public policy or programme) | 5 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 29 | 93.5% | |
| Economic Development and Industry | 1 | 3.2% | |
| Environment | 1 | 3.2% |